Page 2 - Peter Widdows News Today

Clinical stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has announced that global psychedelic therapy and science experts Doctor Bill Richards, Dr Andrea Jungaberle and Professor Matthew Johnson have joined the advisory board of its newly-established subsidiary Clarion Clinics Group.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL), a pharmaceutical company developing cannabis-infused drugs and psychedelic-assisted psychotherapy protocols,...

Clarion Clinics Group Pty Ltd, a wholly-owned subsidiary of Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL), has entered a lease for a property in...

Incannex Healthcare (ASX: IHL) has broken new ground in the emerging field of psychedelic therapies by signing a lease for Australia’s first psychedelic-assisted psychotherapy clinic.

Date: May 05, 2023 Public Announcement Incannex enters a lease for first... | May 5, 2023

MELBOURNE, Australia, May 05, 2023 -- Incannex Healthcare Ltd , a medicinal cannabinoid and psychedelic pharmaceutical development company, is delighted to announce that its subsidiary company,... | May 5, 2023

Incannex Healthcare (ASX: IHL), a clinical-stage psychedelics and cannabinoid pharmaceutical development company, has announced plans to commercialise its psychedelic-assisted psychotherapy business, with the first clinic opening in Melbourne in 2023.

16.03.2023 - Highlights: Incannex plans to open multiple psychedelic-assisted psychotherapy clinics in Australia and overseas.First clinic will open in Melbourne in 2023, followed by rapid expansion based on development of sound operating model.Dr. Paul ... Seite 1

Incannex to open psychedelic psychotherapy clinic’s business with leading Australian psychedelics experts